Regulator of G protein signalling 2 ameliorates angiotensin II-induced hypertension in mice

Experimental Physiology

Volumn 92, Issue 6, 2007, Pages 1014-1022

  Hercule, Hantz C ^a,b   Tank, Jens ^b   Plehm, Ralph ^a   Wellner, Maren ^a   Da Costa Goncalves, Andrey C ^a   Gollasch, Maik ^b   Diedrich, André ^c   Jordan, Jens ^b   Luft, Friedrich C ^a,b   Gross, Volkmar ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1A RECEPTOR; ANGIOTENSIN 1B RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; ENDOTHELIN 1; GUANINE NUCLEOTIDE BINDING PROTEIN; PHENYLEPHRINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIOLE; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL REACTIVITY; CATECHOLAMINE EXCRETION; COMPARATIVE STUDY; CONTROLLED STUDY; GENE EXPRESSION; HEART RATE; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; MOUSE; NONHUMAN; PRESSORECEPTOR REFLEX; PROTEIN EXPRESSION; PROTEIN FUNCTION; SENSITIZATION; SYMPATHETIC TONE; TELEMETRY; URINARY EXCRETION;

EID: 35248820121     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2007.038240     Document Type: Article

References (46)

1. Abramow-Newerly M, Roy AA, Nunn C & Chidiac P (2006). RGS proteins have a signalling complex: interactions between RGS proteins and GPCRs, effectors, and auxiliary proteins. Cell Signal 18, 579 591.
2. Aguilera G (1992). Role of angiotensin II receptor subtypes on the regulation of aldosterone secretion in the adrenal glomerulosa zone in the rat. Mol Cell Endocrinol 90, 53 60.
3. Ardaillou R (1999). Angiotensin II receptors. J Am Soc Nephrol 10 (Suppl. 11 S30 S39.
4. Averill DB, Tsuchihashi T, Khosla MC & Ferrario CM (1994). Losartan, nonpeptide angiotensin II-type 1 (AT1) receptor antagonist, attenuates pressor and sympathoexcitatory responses evoked by angiotensin II and L-glutamate in rostral ventrolateral medulla. Brain Res 665, 245 252.
5. Barrett CJ, Guild SJ, Ramchandra R & Malpas SC (2005). Baroreceptor denervation prevents sympathoinhibition during angiotensin II-induced hypertension. Hypertension 46, 168 172.
6. Barrett CJ, Ramchandra R, Guild SJ, Lala A, Budgett DM & Malpas SC (2003). What sets the long-term level of renal sympathetic nerve activity: a role for angiotensin II and baroreflexes? Circ Res 92, 1330 1336.
7. Bishop VS & Sanderford MG (2000). Angiotensin II modulation of the arterial baroreflex: role of the area postrema. Clin Exp Pharmacol Physiol 27, 428 431.
8. Bonnet F, Cooper ME, Carey RM, Casley D & Cao Z (2001). Vascular expression of angiotensin type 2 receptor in the adult rat: influence of angiotensin II infusion. J Hypertens 19, 1075 1081.
9. Braga AN, da Silva LM, da Silva JR, Fontes WR & dos Santos RA (2002). Effects of angiotensins on day-night fluctuations and stress-induced changes in blood pressure. Am J Physiol Regul Integr Comp Physiol 282, R1663 R1671.
10. Burson JM, Aguilera G, Gross KW & Sigmund CD (1994). Differential expression of angiotensin receptor 1A and 1B in mouse. Am J Physiol Endocrinol Metab 267, E260 E267.
11. Cho H, Harrison K, Schwartz O & Kehrl JH (2003). The aorta and heart differentially express RGS (regulators of G-protein signalling) proteins that selectively regulate sphingosine 1-phosphate, angiotensin-II and endothelin-1 signalling. Biochem J 371, 973 980.
12. Cox BF & Bishop VS (1991). Neural and humoral mechanisms of angiotensin-dependent hypertension. Am J Physiol Heart Circ Physiol 261, H1284 H1291.
13. deBoer RW, Karemaker JM & Strackee J (1987). Hemodynamic fluctuations and baroreflex sensitivity in humans: a beat-to-beat model. Am J Physiol Heart Circ Physiol 253, H680 H689.
14. Du Y, Yao A, Guo D, Inagami T & Wang DH (1995). Differential regulation of angiotensin II receptor subtypes in rat kidney by low dietary sodium. Hypertension 25, 872 877.
15. Esler M (2000). The sympathetic system and hypertension. Am J Hypertens 13, 99S 105S.
16. 2+ sparks as elementary physiological events. Circ Res 83, 1104 1114.
17. Grant SL, Lassegue B, Griendling KK, Ushio-Fukai M, Lyons PR & Alexander RW (2000). Specific regulation of RGS2 messenger RNA by angiotensin II in cultured vascular smooth muscle cells. Mol Pharmacol 57, 460 467.
18. Gross V, Plehm R, Tank J, Jordan J, Diedrich A, Obst M & Luft FC (2002). Heart rate variability and baroreflex function in AT2 receptor-disrupted mice. Hypertension 40, 207 213.
19. Gross V, Tank J, Obst M, Plehm R, Blumer KJ, Diedrich A, Jordan J & Luft FC (2005). Autonomic nervous system and blood pressure regulation in RGS2-deficient mice. Am J Physiol Regul Integr Comp Physiol 288, R1134 R1142.
20. Guimaraes S & Pinheiro H (2005). Functional evidence that in the cardiovascular system AT1 angiotensin II receptors are AT1B prejunctionally and AT1A postjunctionally. Cardiovasc Res 67, 208 215.
21. Henriksen JH, Kastrup J & Christensen NJ (1985). Reduced plasma noradrenaline during angiotensin II-induced acute hypertension in man. Clin Sci (Lond) 68, 621 624.
22. Hepler JR (1999). Emerging roles for RGS proteins in cell signalling. Trends Pharmacol Sci 20, 376 382.
23. Heximer SP, Knutsen RH, Sun X, Kaltenbronn KM, Rhee MH, Peng N, Oliveira-dos-Santos A, Penninger JM, Muslin AJ, Steinberg TH, Wyss JM, Mecham RP & Blumer KJ (2003). Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice. J Clin Invest 111, 445 452.
24. Heximer SP, Watson N, Linder ME, Blumer KJ & Hepler JR (1997). RGS2/G0S8 is a selective inhibitor of Gqα function. Proc Natl Acad Sci U S A 94, 14389 14393.
25. Ichikawa I & Brenner BM (1980). Importance of efferent arteriolar vascular tone in regulation of proximal tubule fluid reabsorption and glomerulotubular balance in the rat. J Clin Invest 65, 1192 1201.
26. Ito M, Oliverio MI, Mannon PJ, Best CF, Maeda N, Smithies O & Coffman TM (1995). Regulation of blood pressure by the type 1A angiotensin II receptor gene. Proc Natl Acad Sci U S A 92, 3521 3525.
27. Iwai N & Inagami T (1992). Identification of two subtypes in the rat type I angiotensin II receptor. FEBS Lett 298, 257 260.
28. Larminie C, Murdock P, Walhin JP, Duckworth M, Blumer KJ, Scheideler MA & Garnier M (2004). Selective expression of regulators of G-protein signaling (RGS) in the human central nervous system. Brain Res Mol Brain Res 122, 24 34.
29. Li Y, Hashim S & Anand-Srivastava MB (2005). Angiotensin II-evoked enhanced expression of RGS2 attenuates Gi-mediated adenylyl cyclase signaling in A10 cells. Cardiovasc Res 66, 503 511.
30. Lohmeier TE, Dwyer TM, Hildebrandt DA, Irwin ED, Rossing MA, Serdar DJ & Kieval RS (2005). Influence of prolonged baroreflex activation on arterial pressure in angiotensin hypertension. Hypertension 46, 1194 1200.
31. Lumbers ER, McCloskey DI & Potter EK (1979). Inhibition by angiotensin II of baroreceptor-evoked activity in cardiac vagal efferent nerves in the dog. J Physiol 294, 69 80.
32. Ma X, Abboud FM & Chapleau MW (2001). A novel effect of angiotensin on renal sympathetic nerve activity in mice. J Hypertens 19, 609 618.
33. Ma X, Sigmund CD, Hingtgen SD, Tian X, Davisson RL, Abboud FM & Chapleau MW (2004). Ganglionic action of angiotensin contributes to sympathetic activity in reninangiotensinogen transgenic mice. Hypertension 43, 312 316.
34. Masilamani S, Kim GH, Mitchell C, Wade JB & Knepper MA (1999). Aldosterone-mediated regulation of ENaC α, β, and γ subunit proteins in rat kidney. J Clin Invest 104, R19 R23.
35. Mattes A, Witte K, Hohmann W & Lemmer B (1991). PHARMFIT - a nonlinear fitting program for pharmacology. Chronobiol Int 8, 460 476.
36. Navar LG, Carmines PK, Huang WC & Mitchell KD (1987). The tubular effects of angiotensin II. Kidney Int Suppl. 20, S81 S88.
37. Obst M, Gross V & Luft FC (2004). Systemic hemodynamics in non-anesthetized L-NAME- and DOCA-salt-treated rats. J Hypertens 22, 1889 1894.
38. Obst M, Tank J, Plehm R, Blumer KJ, Diedrich A, Jordan J, Luft FC & Gross V (2006). NO-dependent blood pressure regulation in RGS2-deficient mice. Am J Physiol Regul Integr Comp Physiol 290, R1012 R1019.
39. Reid IA (1992). Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure. Am J Physiol Endocrinol Metab 262, E763 E778.
40. Ryan MJ, Didion SP, Mathur S, Faraci FM & Sigmund CD (2004). Angiotensin II-induced vascular dysfunction is mediated by the AT1A receptor in mice. Hypertension 43, 1074 1079.
41. Tang M, Wang G, Lu P, Karas RH, Aronovitz M, Heximer SP, Kaltenbronn KM, Blumer KJ, Siderovski DP, Zhu Y & Mendelsohn ME (2003). Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure. Nat Med 9, 1506 1512.
42. Westermann J, Hubl W, Kaiser N & Salewski L (2002). Simple, rapid and sensitive determination of epinephrine and norepinephrine in urine and plasma by non-competitive enzyme immunoassay, compared with HPLC method. Clin Lab 48, 61 71.
43. Xue B, Gole H, Pamidimukkala J & Hay M (2003). Role of the area postrema in angiotensin II modulation of baroreflex control of heart rate in conscious mice. Am J Physiol Heart Circ Physiol 284, H1003 H1007.
44. Zhong H & Neubig RR (2001). Regulator of G protein signaling proteins: novel multifunctional drug targets. J Pharmacol Exp Ther 297, 837 845.
45. Zhou Y, Chen Y, Dirksen WP, Morris M & Periasamy M (2003). AT1b receptor predominantly mediates contractions in major mouse blood vessels. Circ Res 93, 1089 1094.
46. Zhou Y, Dirksen WP, Chen Y, Morris M, Zweier JL & Periasamy M (2005). A major role for AT1b receptor in mouse mesenteric resistance vessels and its distribution in heart and neuroendocrine tissues. J Mol Cell Cardiol 38, 693 696.